ScienceUpdated 23 min ago
Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.
Continue reading on Phys.org
Read full story Hello Headlines links you to the original publisher for the full story.




